BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 13420219)

  • 1. [Behavior of anti-Vi antibodies during typhoid fever].
    GOSCICKI J; KUKULSKA T; STEMPIEN R
    Przegl Epidemiol; 1956; 10(4):325-32. PubMed ID: 13420219
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of anti O, anti H, and anti Vi antibodies in phagocytic reaction].
    SKURSKI A; JARMOC Z
    Med Dosw Mikrobiol; 1953; 5(3):356-7. PubMed ID: 13132461
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of antityphoid antibodies O, H and Vi found in normal subjects during an epidemic of typhoid fever.
    OLIVO R; VENTURI R
    Ann Sanita Pubblica; 1953; 14(5):1245-53. PubMed ID: 13148974
    [No Abstract]   [Full Text] [Related]  

  • 4. [Incomplete antibodies in typhoid fever. II. Vi agglutination].
    POTUZNIK V; HAVLIK J
    Cesk Epidemiol Mikrobiol Imunol; 1957 Sep; 6(5):322-4. PubMed ID: 13479888
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigation into the existence of functionally deficient Vi antibody. I. An analysis of the protective effects of S. typhi O and Vi antibodies on intraperitoneal typhoid infection of mice.
    SPAUN J; BENTZON MW
    Acta Pathol Microbiol Scand; 1957; 41(4):327-41. PubMed ID: 13469411
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of research on Vi antibodies in typhoid carriers].
    GABBRIELLI G
    Boll Ist Sieroter Milan; 1957; 36(7-8):373-5. PubMed ID: 13471772
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of complete and incomplete antibodies in typhoid fever and brucellosis treated with antibiotics].
    PARDELLI L; TOSI E
    Minerva Pediatr; 1954 Jul; 6(14):550-5. PubMed ID: 13203347
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Typhoid vaccine; Vi antigen and Vi antibody.
    SPAUN J
    Acta Pathol Microbiol Scand Suppl (1926); 1957; 123():1-79. PubMed ID: 13487335
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution to the study of immunity in typhoid fever].
    Gavrila I; Turcas C
    J Med Lyon; 1966 May; 47(99):867-72. PubMed ID: 5937628
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isolation of complete and incomplete O(9, 12) and Vi antibodies in sera from active and convalescent cases of typhoid fever].
    POTUVNIK V; GAVLIK J
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Dec; 29(12):78-82. PubMed ID: 13626144
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation of typhoid vaccine from separated antigenic components. I. Preparation of purified O and Vi antigens.
    GUNDA L; JOO I; RICHTER P; VALI A
    Acta Microbiol Acad Sci Hung; 1957; 4(3):263-77. PubMed ID: 13487256
    [No Abstract]   [Full Text] [Related]  

  • 13. [Method for the demonstration of O antibodies (9, 12) in patients with typhoid fever].
    POTUZNIK V; HAVLIK J
    Cesk Epidemiol Mikrobiol Imunol; 1958 Jan; 7(1):36-9. PubMed ID: 13537031
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid diagnosis of typhoid fever by enzyme-linked immunosorbent assay detection of Salmonella serotype typhi antigens in urine.
    Fadeel MA; Crump JA; Mahoney FJ; Nakhla IA; Mansour AM; Reyad B; El Melegi D; Sultan Y; Mintz ED; Bibb WF
    Am J Trop Med Hyg; 2004 Mar; 70(3):323-8. PubMed ID: 15031525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation into the existence of functionally deficient Vi antibody. II. Passive mouse protection tests with sera prepared by immunization with different typhoid vaccines.
    SPAUN J; BENTZON MW
    Acta Pathol Microbiol Scand; 1957; 41(4):342-52. PubMed ID: 13469412
    [No Abstract]   [Full Text] [Related]  

  • 16. [Method of detection of Vi antibodies].
    SEMBRAT-NIEWIADOMSKA Z; KURPIERS J
    Med Dosw Mikrobiol; 1955; 7(2):191-6. PubMed ID: 13244325
    [No Abstract]   [Full Text] [Related]  

  • 17. [A study of typhoid-paratyphoid vaccines obtained from microbial extracts adsorbed on a mineral support. I. Comparative immunobiological study of some antigenic extracts obtained from S. typhi and other enterobacteriaceae containing antigen Vi].
    TOMA S; SORU E; BARBER C; CRITAENCO V; BOGOKOWSKY B
    C R Seances Soc Biol Fil; 1956; 150(12):2088-91. PubMed ID: 13437529
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the effect of vaccinations against typhoid fever; fatality rate in vaccinated and unvaccinated patients with typhoid fever].
    PƁACHCINSKA J
    Przegl Epidemiol; 1953; 7(4):273-6. PubMed ID: 13155665
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the typhoid agglutinin titres in patients treated with typhoid endotoxin].
    Lipnicki B; Skrzypczak K
    Klin Oczna; 1968; 38(4):815-8. PubMed ID: 5702393
    [No Abstract]   [Full Text] [Related]  

  • 20. Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
    Pulickal AS; Pollard AJ
    Expert Rev Vaccines; 2007 Jun; 6(3):293-5. PubMed ID: 17542742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.